全文获取类型
收费全文 | 81610篇 |
免费 | 9597篇 |
国内免费 | 399篇 |
专业分类
耳鼻咽喉 | 696篇 |
儿科学 | 1991篇 |
妇产科学 | 3131篇 |
基础医学 | 7973篇 |
口腔科学 | 1662篇 |
临床医学 | 21372篇 |
内科学 | 16389篇 |
皮肤病学 | 864篇 |
神经病学 | 5582篇 |
特种医学 | 2092篇 |
外国民族医学 | 2篇 |
外科学 | 10699篇 |
综合类 | 1045篇 |
现状与发展 | 1篇 |
一般理论 | 103篇 |
预防医学 | 6865篇 |
眼科学 | 1868篇 |
药学 | 4481篇 |
中国医学 | 140篇 |
肿瘤学 | 4650篇 |
出版年
2023年 | 1026篇 |
2022年 | 465篇 |
2021年 | 1373篇 |
2020年 | 1321篇 |
2019年 | 1201篇 |
2018年 | 2302篇 |
2017年 | 2164篇 |
2016年 | 2353篇 |
2015年 | 2583篇 |
2014年 | 3255篇 |
2013年 | 4520篇 |
2012年 | 4179篇 |
2011年 | 4776篇 |
2010年 | 3368篇 |
2009年 | 3493篇 |
2008年 | 4635篇 |
2007年 | 4718篇 |
2006年 | 4553篇 |
2005年 | 4548篇 |
2004年 | 4241篇 |
2003年 | 3801篇 |
2002年 | 3712篇 |
2001年 | 1194篇 |
2000年 | 893篇 |
1999年 | 1135篇 |
1998年 | 1311篇 |
1997年 | 1293篇 |
1996年 | 1124篇 |
1995年 | 1049篇 |
1994年 | 871篇 |
1993年 | 762篇 |
1992年 | 779篇 |
1991年 | 743篇 |
1990年 | 650篇 |
1989年 | 617篇 |
1988年 | 532篇 |
1987年 | 502篇 |
1986年 | 478篇 |
1985年 | 560篇 |
1984年 | 533篇 |
1983年 | 490篇 |
1982年 | 609篇 |
1981年 | 531篇 |
1980年 | 535篇 |
1979年 | 376篇 |
1978年 | 378篇 |
1977年 | 385篇 |
1976年 | 326篇 |
1975年 | 324篇 |
1974年 | 276篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
101.
102.
Edward M Messing Judith Manola George Wilding Kathleen Propert Jonathan Fleischmann E David Crawford J Edson Pontes Richard Hahn Donald Trump 《Journal of clinical oncology》2003,21(7):1214-1222
PURPOSE: To evaluate the role of adjuvant interferon alfa after complete resection of locally extensive renal cell carcinoma. PATIENTS AND METHODS: A total of 283 eligible patients with pT3-4a and/or node-positive disease were randomly assigned after radical nephrectomy and lymphadenectomy to observation or to interferon alfa-NL (Wellferon, Burroughs-Wellcome, Research Park, NC) given daily for 5 days every 3 weeks for up to 12 cycles. Patients were stratified on the basis of pathologic stage. Patients remained on treatment until documented recurrence, excessive toxicity, or patient/physician preference deemed removal appropriate. RESULTS: At median follow-up of 10.4 years, median survival was 7.4 years in the observation arm and 5.1 year in the treatment arm (log-rank P =.09). Median recurrence-free survival was 3.0 years in the observation arm and 2.2 years in the interferon arm (P =.33). Performance status (P =.003), nodal status (N2 v N0, P <.0001), and tumor stage (P =.0002) were significant prognostic factors in multivariate analysis. A proportional hazards model examining the effects of treatment arm and time to recurrence on survival after recurrence among patients who recurred found that random assignment to interferon treatment (P =.009) and shorter time to recurrence (P <.0001) were independent predictors of shorter survival after recurrence. Although no lethal toxicities were observed, severe (grade 4) toxicities including neutropenia, myalgia, fatigue, depression, and other neurologic toxicities occurred in 11.4% of those randomly assigned to interferon treatment. CONCLUSION: Adjuvant treatment with interferon did not contribute to survival or relapse-free survival in this group of patients. 相似文献
103.
104.
105.
106.
A 37-year-old male with history of alcohol abuse presented to us with nausea, vomiting, and abdominal pain with ascites. He was diagnosed with alcoholic liver disease with coagulopathy and pancreatitis. During hospitalization, the patient developed intra-abdominal hemorrhage. He was treated with platelets, packed red blood cells and fresh frozen plasma without any improvement. Following this he was treated with activated recombinant factor VII (90 microg/kg), which resulted in normalization of the prothrombin time and the activated partial thromboplastin time and stabilization of hematocrit within a few hours. We review the current literature on the approved and off-label use of activated recombinant factor VII. 相似文献
107.
108.
109.
Basil D'Souza George Dimitroulis 《Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics》2007,104(4):e59-e61
This is a case study of a patient with recurrent synovial chondromatosis. It shows some relevant images. It also provides possibilities for why this patient may have had a recurrence and how this was managed. 相似文献
110.
George A Kaysen 《Journal of renal nutrition》2007,17(1):4-8
Cardiovascular risk increases with each decrement in renal function. Low-density lipoprotein (LDL) cholesterol levels are not associated with increased mortality, but high-density lipoprotein (HDL) levels are inversely associated with cardiovascular risk. Lipoprotein composition with increased abundance of small dense LDL and HDL and reduced levels of more buoyant isoforms is similar to what is found in states of insulin resistance and in the metabolic syndrome (MS). In both cases, high triglyceride levels are associated with reduced HDL levels. Chronic kidney disease (CKD) is itself associated with increasing insulin resistance as renal function fails. In both instances, decreased levels of apo A-I and apo A-II are a consequence of increased fractional catabolic rate (FCR), resulting from a predominance of small HDL particles. HDL maturation is impaired in CKD through decreased activity of lecithin:cholesterol acyltransferase (LCAT), and increased cholesterol ester transfer protein (CETP) activity in MS shuttles triglycerides back into HDL, thereby destabilizing it. Whether insulin resistance is entirely responsible for disorders of HDL metabolism in CKD, or whether the process is a result of unrelated pathophysiology, is currently unknown. 相似文献